Eagle Pharmaceuticals Inc (EGRX) — Free Cash Flow Generation Index
Eagle Pharmaceuticals Inc (EGRX) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $37.55 Million represents 1% of operating cash flow ($37.56 Million). Explore Eagle Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eagle Pharmaceuticals Inc Free Cash Flow Generation Index (2016–2022)
Historical FCF Generation Index trend for Eagle Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see Eagle Pharmaceuticals Inc operating cash flow efficiency.
Annual Free Cash Flow Generation for Eagle Pharmaceuticals Inc (2016–2022)
Year-by-year Free Cash Flow Generation Index for Eagle Pharmaceuticals Inc. Check Eagle Pharmaceuticals Inc (EGRX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.00x | $30.80 Million | $30.80 Million | $178.00K | ▲ +1.2% |
| 2021 | 0.99x | $27.90 Million | $28.22 Million | $323.00K | ▲ +0.4% |
| 2020 | 0.98x | $48.75 Million | $49.50 Million | $747.00K | ▼ -0.1% |
| 2019 | 0.99x | $55.21 Million | $55.99 Million | $777.00K | ▼ -1.1% |
| 2018 | 1.00x | $52.25 Million | $52.38 Million | $133.00K | ▲ +9.4% |
| 2017 | 0.91x | $53.73 Million | $58.92 Million | $5.19 Million | ▲ +49.2% |
| 2016 | 0.61x | $32.52 Million | $53.21 Million | $20.69 Million | — |